- Home
- TNYA
as 10-04-2024 4:00pm EST
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 190.9M | IPO Year: | 2021 |
| Target Price: | $15.25 | AVG Volume (30 days): | 519.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.53 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.66 - $7.01 | Next Earning Date: | 11-06-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 360.00% |
Stock Insider Trading Activity of Tenaya Therapeutics Inc. (TNYA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Tingley Whittemore | TNYA | Chief Medical Officer | Aug 16 '24 | Sell | $2.89 | 7,428 | $21,500.35 | 108,731 | |
| Ali Faraz | TNYA | Chief Executive Officer | Aug 16 '24 | Sell | $2.89 | 9,748 | $28,215.59 | 192,277 |
Latest Tenaya Therapeutics Inc. News
TNYA Breaking Stock News: Dive into TNYA Ticker-Specific Updates for Smart Investing
Simply Wall St.
15 days ago
Owning 43% shares,institutional owners seem interested in Tenaya Therapeutics, Inc. (NASDAQ:TNYA),
GlobeNewswire
a month ago
Tenaya Therapeutics to Participate in Upcoming Investment Conferences
GlobeNewswire
2 months ago
Tenaya Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
3 months ago
Tenaya Therapeutics Announces Research Leadership Updates
GlobeNewswire
4 months ago
Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit
MT Newswires
4 months ago
William Blair Starts Tenaya Therapeutics With Outperform Rating
Motley Fool
4 months ago
BigBear.ai Stock: Buy, Sell, or Hold?
AFP
4 months ago
Indonesia's first Olympic gymnast encourages others to 'dream higher'
Compare TNYA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TNYA Tenaya Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.